- Home
- BBNX vs AOD Comparison
BBNX vs AOD Comparison
Compare BBNX & AOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBNX
- AOD
- Stock Information
- Founded
- BBNX 2015
- AOD 2006
- Country
- BBNX United States
- AOD United Kingdom
- Employees
- BBNX N/A
- AOD N/A
- Industry
- BBNX Medical/Dental Instruments
- AOD Investment Managers
- Sector
- BBNX Health Care
- AOD Finance
- Exchange
- BBNX Nasdaq
- AOD Nasdaq
- Market Cap
- BBNX 967.6M
- AOD 970.0M
- IPO Year
- BBNX 2025
- AOD N/A
- Fundamental
- Price
- BBNX $27.09
- AOD $9.40
- Analyst Decision
- BBNX Strong Buy
- AOD
- Analyst Count
- BBNX 11
- AOD 0
- Target Price
- BBNX $28.09
- AOD N/A
- AVG Volume (30 Days)
- BBNX 793.5K
- AOD 423.5K
- Earning Date
- BBNX 10-28-2025
- AOD 01-01-0001
- Dividend Yield
- BBNX N/A
- AOD 12.95%
- EPS Growth
- BBNX N/A
- AOD 213.63
- EPS
- BBNX N/A
- AOD 1.93
- Revenue
- BBNX $88,570,000.00
- AOD $72,962,082.00
- Revenue This Year
- BBNX $52.13
- AOD N/A
- Revenue Next Year
- BBNX $36.07
- AOD N/A
- P/E Ratio
- BBNX N/A
- AOD $4.44
- Revenue Growth
- BBNX 67.01
- AOD N/A
- 52 Week Low
- BBNX $8.89
- AOD $6.99
- 52 Week High
- BBNX $30.47
- AOD $9.14
- Technical
- Relative Strength Index (RSI)
- BBNX 58.70
- AOD 45.09
- Support Level
- BBNX $24.33
- AOD $9.13
- Resistance Level
- BBNX $29.22
- AOD $9.55
- Average True Range (ATR)
- BBNX 2.06
- AOD 0.12
- MACD
- BBNX 0.05
- AOD -0.02
- Stochastic Oscillator
- BBNX 52.89
- AOD 49.05
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.